Relmada Therapeutics (RLMD) Finished Goods (2012 - 2013)
Relmada Therapeutics (RLMD) posted Finished Goods of $3,169 for FY2013, down 50.5% from $6,405 in FY2012.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Finished Goods (2012 - 2013) Analysis & Trends
- Business Quant data shows RLMD's Finished Goods at $6,405 in FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Relmada Therapeutics | 361.29 Mn | -197.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2013 | 4,734.00 |
| Aug 31, 2013 | 3,169.00 |
| May 31, 2013 | 2,369.00 |
| Feb 28, 2013 | 2,690.00 |
| Aug 31, 2012 | 6,405.00 |
API Access
Relmada Therapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();